| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to the authority of the Cancer Prevention and Research |
|
|
Institute of Texas to award grants for endometriosis research. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 102.002, Health and Safety Code, is |
|
|
amended to read as follows: |
|
|
Sec. 102.002. PURPOSES. The Cancer Prevention and Research |
|
|
Institute of Texas is established to: |
|
|
(1) create and expedite innovation in the area of |
|
|
cancer research and in enhancing the potential for a medical or |
|
|
scientific breakthrough in the prevention of cancer and cures for |
|
|
cancer, including research on whether endometriosis may lead to or |
|
|
increase the incidence of cancer in humans; |
|
|
(2) attract, create, or expand research capabilities |
|
|
of public or private institutions of higher education and other |
|
|
public or private entities that will promote a substantial increase |
|
|
in cancer research and in the creation of high-quality new jobs in |
|
|
this state; and |
|
|
(3) develop and implement the Texas Cancer Plan. |
|
|
SECTION 2. Section 102.051(a), Health and Safety Code, is |
|
|
amended to read as follows: |
|
|
(a) The institute: |
|
|
(1) may award [make] grants to provide funds to public |
|
|
or private persons to implement the Texas Cancer Plan, and may award |
|
|
[make] grants to institutions of learning and to advanced medical |
|
|
research facilities and collaborations in this state for: |
|
|
(A) research into the causes of and cures for all |
|
|
types of cancer in humans, including research on whether |
|
|
endometriosis leads to or increases the incidence of cancer and the |
|
|
causes of, biological markers of, and treatment efficacy for |
|
|
endometriosis; |
|
|
(B) facilities for use in research into the |
|
|
causes of and cures for cancer; |
|
|
(C) research, including translational research, |
|
|
to develop therapies, protocols, medical pharmaceuticals, or |
|
|
procedures for the cure or substantial mitigation of all types of |
|
|
cancer in humans; and |
|
|
(D) cancer prevention and control programs in |
|
|
this state to mitigate the incidence of all types of cancer in |
|
|
humans; |
|
|
(2) may support institutions of learning and advanced |
|
|
medical research facilities and collaborations in this state in all |
|
|
stages in the process of finding the causes of all types of cancer |
|
|
in humans and developing cures, from laboratory research to |
|
|
clinical trials and including programs to address the problem of |
|
|
access to advanced cancer treatment; |
|
|
(3) may establish the appropriate standards and |
|
|
oversight bodies to ensure the proper use of funds authorized under |
|
|
this chapter for cancer research and facilities development; |
|
|
(4) may employ necessary staff to provide |
|
|
administrative support; |
|
|
(5) shall continuously monitor contracts and |
|
|
agreements authorized by this chapter and ensure that each grant |
|
|
recipient complies with the terms and conditions of the grant |
|
|
contract; |
|
|
(6) shall ensure that all grant proposals comply with |
|
|
this chapter and rules adopted under this chapter before the |
|
|
proposals are submitted to the oversight committee for approval; |
|
|
and |
|
|
(7) shall establish procedures to document that the |
|
|
institute, its employees, and its committee members appointed under |
|
|
this chapter comply with all laws and rules governing the peer |
|
|
review process and conflicts of interest. |
|
|
SECTION 3. Section 102.201(c), Health and Safety Code, is |
|
|
amended to read as follows: |
|
|
(c) The fund may be used only to pay for: |
|
|
(1) grants for cancer research and for cancer research |
|
|
facilities in this state to realize therapies, protocols, and |
|
|
medical procedures for the cure or substantial mitigation of all |
|
|
types of cancer in humans, including research on whether |
|
|
endometriosis leads to or increases the incidence of cancer and the |
|
|
causes of, biological markers of, and treatment efficacy for |
|
|
endometriosis; |
|
|
(2) the purchase, subject to approval by the |
|
|
institute, of laboratory facilities by or on behalf of a state |
|
|
agency or grant recipient; |
|
|
(3) grants to public or private persons to implement |
|
|
the Texas Cancer Plan; |
|
|
(4) the operation of the institute; |
|
|
(5) grants for cancer prevention and control programs |
|
|
in this state to mitigate the incidence of all types of cancer in |
|
|
humans; and |
|
|
(6) debt service on bonds issued as authorized by |
|
|
Section 67, Article III, Texas Constitution. |
|
|
SECTION 4. This Act takes effect September 1, 2027. |